Discovery of Markers of Exposure Specific to Bites of Lutzomyia longipalpis, the Vector of Leishmania infantum chagasi in Latin America by Teixeira, Clarissa et al.
Discovery of Markers of Exposure Specific to Bites of
Lutzomyia longipalpis, the Vector of Leishmania











3, Ana Paula de Souza











1Vector Molecular Biology Section, Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville,
Maryland, United States of America, 2Department of Natural Sciences, University of Maryland Eastern Shore, Princess Anne, Maryland, United States of America,
3Universidade Federal do Maranha ˜o, Sa ˜o Luis, Maranha ˜o, Brazil, 4Centro de Pesquisas Goncalo Moniz–FIOCRUZ, Salvador, Bahia, Brazil, 5Laboratorio de Leishmanioses,
Instituto de Doencas Tropicais Natan Portella and Universidade Federal do Piaui, Teresina, Piaui, Brazil, 6Department of Parasitology, Faculty of Science, Charles University
in Prague, Prague, Czech Republic
Abstract
Background: Sand flies deliver Leishmania parasites to a host alongside salivary molecules that affect infection outcomes.
Though some proteins are immunogenic and have potential as markers of vector exposure, their identity and vector
specificity remain elusive.
Methodology/Principal Findings: We screened human, dog, and fox sera from endemic areas of visceral leishmaniasis to
identify potential markers of specific exposure to saliva of Lutzomyia longipalpis. Human and dog sera were further tested
against additional sand fly species. Recombinant proteins of nine transcripts encoding secreted salivary molecules of Lu.
longipalpis were produced, purified, and tested for antigenicity and specificity. Use of recombinant proteins corresponding
to immunogenic molecules in Lu. longipalpis saliva identified LJM17 and LJM11 as potential markers of exposure. LJM17 was
recognized by human, dog, and fox sera; LJM11 by humans and dogs. Notably, LJM17 and LJM11 were specifically
recognized by humans exposed to Lu. longipalpis but not by individuals exposed to Lu. intermedia.
Conclusions/Significance: Salivary recombinant proteins are of value as markers of vector exposure. In humans, LJM17 and
LJM11 emerged as potential markers of specific exposure to Lu. longipalpis, the vector of Leishmania infantum chagasi in
Latin America. In dogs, LJM17, LJM11, LJL13, LJL23, and LJL143 emerged as potential markers of sand fly exposure. Testing
these recombinant proteins in large scale studies will validate their usefulness as specific markers of Lu. longipalpis exposure
in humans and of sand fly exposure in dogs.
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Introduction
Sand fly salivary proteins play a major role in blood feeding and
Leishmania transmission [1–3]. Exposure to sand fly salivary proteins
induces both cellular immunity and specific antibodies [3,4]. A
relationship between the level of specific antibodies to saliva, vector
exposure and risk of contracting disease has been demonstrated for
different vector-host models [5–9]. Production of antibodies against
mosquito and tick saliva not only contributed to development of host
allergic reactions but was strongly related to risk of disease development
[5,10]. Similarly, in an endemic area of Senegal, production of
antibodies against Anopheles gambiae salivary proteins was identified as an
indicator of the risk of malaria [10]. This correlation was also observed
for tick exposure, where antibody production against tick saliva was
associated with self-reported tick exposure and Lyme disease [11].
Recently, saliva of Triatoma infestans was shown to be a potential marker
for vector infestation in domestic animals [12]. Therefore, the detection
of antibodies against the saliva of hematophagous insect vectors could
be used as an indicator of vector exposure and in some instances as an
indicator for risk of contracting disease.
Previous work shows that humans and animals exposed to sand
fly bites or immunized with saliva can develop antibodies that
recognize specific salivary proteins [4,7,13–15]. In Sa ˜o Luis, an area
of endemic visceral leishmaniasis (VL) in Maranha ˜o, Brazil, the
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withprotection and thedevelopmentof anti-Leishmania delayed-type
hypersensitivity response [7]. Furthermore, individuals that poorly
recognized salivary proteins developed anti-Leishmania antibodies
associated with disease progression [7]. In contrast, in areas
endemic for cutaneous leishmaniasis (CL)—such as Canoa (Bahia,
Brazil) and Sanliurfa (Turkey)—the presence of anti-saliva antibod-
ies correlated with risk of contracting disease [16,17].
The presence of antibodies to sand fly salivary proteins has also
been demonstrated in animal reservoirs of leishmaniasis. In
canines, two sand fly salivary proteins were recognized by sera
of infected dogs from an endemic VL area in Brazil [18].
Hostomska et al. [14] reported the presence of anti-saliva
antibodies to six different sand fly proteins in dogs experimentally
exposed to Lutzomyia longipalpis bites. Importantly, foxes captured
in Teresina, an endemic VL area in Brazil, also showed high levels
of anti-saliva antibodies, particularly to a 44-kDa salivary protein
from Lu. longipalpis, suggesting exposure to bites of this vector [19].
Hence, vector salivary proteins also represent a potential tool as
markers of exposure to important reservoirs of disease.
Identification of the sand fly salivary proteins recognized by the
mammalian host will not only increase our understanding of
vector-host interactions but will also aid in developing new
epidemiological tools to correlate host exposure to vector sand flies
with immunity or susceptibility to leishmaniasis. It will also help
identify potential reservoirs of Leishmania. Here we describe a
practical functional transcriptomic approach for the identification
of the Lu. longipalpis salivary proteins most recognized by humans
and canids (dogs and foxes) using sera from Sa ˜o Luis and Teresina,
endemic areas for VL in Brazil [15,20].
Methods
Sand flies and preparation of salivary gland homogenate
(SGH)
Lu. longipalpis (Jacobina strain) were reared at LMVR, NIAID,
USA; Lu. verrucarum (Peru strain) and Phlebotomus perniciosus (Italy
strain) at WRAIR, USA; Lu. intermedia (Corte de Pedra strain) were
obtained from CPqGM (FIOCRUZ, Bahia, Brazil). Females were
used for dissection of salivary glands 5–8 days post-eclosion; SGH
was prepared as described elsewhere [21]. Briefly, salivary glands
were dissected and stored in sterile PBS (pH 7.4) at 270uC. To
obtain the homogenate, salivary glands were disrupted by
ultrasonication and the supernatant collected after centrifugation
at 15,000g for 2 minutes.
Serum samples
A total of 14 human sera from from a VL-endemic region in
Sa ˜o Luis (Maranha ˜o, Brazil) [15] and 6 from a CL-endemic region
in Canoa (Bahia, Brazil) [22] were used in this study. Informed
written consent was obtained from parents or legal guardians of
minors. The project was approved by the institutional review
board from the Federal University of Bahia (1993) and the Federal
University of Maranhao (1996). Dog and fox (Cerdocyon thous) sera
(total of 8 and 11, respectively) were from animals captured in a
VL-endemic area around Teresina (Piaui, Brazil) [19]. Fox and
dog studies were approved in 2000 by the Brazilian agency for
protection of the wildlife (IBAMA/PI) and in 2005 by the Federal
University of Piaui. Sera were also obtained from dogs (total of 6)
experimentally exposed to Lu. longipalpis [14]. Dog studies were
approved by Bayer Health Care AG (Leverkusen, Germany) and
handled in accordance with the European guidelines for animal
husbandry.
Cloning of Lu. longipalpis salivary transcripts into a
VR2001-TOPO vector
DNA was amplified by polymerase chain reaction (PCR) using a
forward primer deduced from the amino-terminus and a reverse
primer encoding a hexhistidine motif. PCR amplification
conditions were: one hold of 94uC 5 min, two cycles of 94uC
30 s, 48uC 1 min, 72uC 1 min, 23 cycles of 94uC3 0s ,5 8 uC
1 min, 72uC 1 min, and one hold of 72uC 7 min. The PCR
product was cloned into the VR2001-TOPO vector and
sequenced [23].
Polyclonal antibodies against Lu. longipalpis salivary
protein
A plasmid encoding a distinct salivary protein (1 mg/ml) was
injected intradermally into female Swiss Webster mice in 10 ml,
three times at two-week intervals to generate polyclonal antibodies
for each of the nine selected candidates [23].
Expression and high-performance liquid
chromatography (HPLC) purification of His-tagged Lu.
longipalpis salivary proteins
Recombinant proteins were produced by transfecting 293-F
cells (Invitrogen) with plasmid following the manufacturer’s
recommendations. After 72 h, the supernatant was recovered,
filtered and concentrated to 30 ml in an Amicon concentrator
device (Millipore) in the presence of Buffer A (20 mM NaH2PO4,
20 mM Na2HPO4, pH 7.4, 500 mM NaCl). A HiTrap chelating
HP column (GE Healthcare) was charged with 5 ml of 0.1M
Ni2SO4. The concentrated protein was added to the HiTrap
chelating HP column that was then connected to a Summit station
HPLC system (Dionex, Sunnyvale, CA) consisting of a P680
HPLC pump and a PDA-100 detector. The column was
equilibrated for 30 min with Buffer A at 1 ml/min. Elution
conditions were: 0-5 min, 100% Buffer A; 5-15 min, a gradient of
0% to 100% Buffer B ( Buffer A+50 mM imidazole); 15-20 min, a
gradient of 0% C (Buffer A+500 mM imidazole) to 10% C (90%
Author Summary
Leishmania parasites are transmitted by the bite of an
infected vector sand fly that injects salivary molecules into
the host skin during feeding. Certain salivary molecules
can produce antibodies and can be used as an indicator of
exposure to a vector sand fly and potentially the disease it
transmits. Here we identified potential markers of specific
exposure to the sand fly Lutzomyia longipalpis, the vector
of visceral leishmaniasis in Latin America. Initially, we
determined which of the salivary proteins produce
antibodies in humans, dogs, and foxes from areas endemic
for the disease. To identify potential specific markers of
vector exposure, we produced nine different recombinant
salivary proteins from Lu. longipalpis and tested for their
recognition by individuals exposed to another human-
biting sand fly, Lu. intermedia, that transmits cutaneous
leishmaniasis and commonly occurs in the same endemic
areas as Lu. longipalpis. Two of the nine salivary proteins
were recognized only by humans exposed to Lu. long-
ipalpis, suggesting they are immunogenic proteins and
may be useful in epidemiological studies. The identifica-
tion of specific salivary proteins as potential markers of
exposure to vector sand flies will increase our understand-
ing of vector–human interaction, bring new insights to
vector control, and in some instances act as an indicator
for risk of acquiring disease.
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C to 20% C (80% B); 30-35 min, 80% B and 20% C; 35-40 min, a
gradient of 20% C to 100%C; and 40-50 min, 100% C. Eluted
proteins were detected at 280 nm and collected every minute on a
96-well microtiter plate using a Foxy 200 fraction collector
(Teledyne ISCO).
Five-microliter aliquots of all fractions were blotted on
nitrocellulose and blocked with TBS-tween 3% non-fat milk for
1 h and then incubated for 1 h with anti-saliva antibodies, washed,
and incubated for 1 h with an anti-mouse IgG (H+L) alkaline
phosphatase-conjugated secondary antibody (Promega). Positive
fractions were developed with Western Blue stabilized substrate for
alkaline phosphatase (Promega). Positive fractions were run on
sodium dodecyl sulfate (SDS-PAGE) and silver stained using
SilverQuest (Invitrogen). Imidazole was removed from positive
fractions by dialysis overnight against PBS, pH 7.4.
Western blotting using human, dog, and fox sera
Salivary glands (40 pairs approximately equivalent to 40 mg
total protein) or soluble recombinant sand fly salivary proteins
(20 mg) were run on a 4–20% Tris-glycine gel or on a 4–12%
NuPAGE gel. After transfer to a nitrocellulose membrane using
the iBlot device (Invitrogen), the membrane was blocked with 3%
(w/v) nonfat dry milk in Tris-buffered saline (TBS)-0.05%
Tween, pH 8.0, overnight at 4uC. After washing with TBS-T,
pH 8.0, the membrane was placed on a mini-protean II
multiscreen apparatus (Bio-Rad, Hercules, CA), and different
lanes were incubated with various sera (1:80 dilution, human and
dog sera; 1:50 dilution, fox sera) for 3 h at room temperature.
After washing with TBS-T, pH 8.0, three times for 5 min, the
membrane was incubated with either anti-dog IgG (H+L)
alkaline phosphate-conjugated antibody (1:10,000) (Jackson
Immuno Research) for 1 h at room temperature for dog and
fox sera or with anti-human IgG alkaline phosphate-conjugated
antibody (1:8,000) (Sigma) for human sera. Membranes were
developed by addition of Western Blue stabilized substrate for
alkaline phosphatase (Promega), and the reaction was stopped by
washing the membrane with deionized water.
Results
Recognition of salivary proteins from the sand fly Lu.
longipalpis by sera from different hosts
Lu. longipalpis salivary glands contain a large number of secreted
proteins (figure 1A). Fourteen human sera from individuals living
in Sa ˜o Luis, an area where Lu. longipalpis predominates, recognized
a considerable number of these proteins, mainly between 15 and
65 kDa (figure 1B). Eight dog sera from Teresina recognized a
large number of salivary proteins, many of the same size as human
sera as well as several proteins of different sizes (figure 1B). As for
foxes, 11 sera collected in the same endemic area as dogs
recognized only a few salivary proteins and only one strongly of
approximately 50 kDa (figure 1B).
Host-specific recognition of Lu. longipalpis salivary
proteins
To determine the specificity of human and dog sera for Lu.
longipalpis salivary proteins, we tested the most reactive human
(two) and dog (one) sera against salivary proteins from other sand
fly species including Lu. intermedia which transmits CL in South
America [24], Lu. verrucarum which transmits CL in Central and
South America [25], and Phlebotomus perniciosus which transmits VL
in Mediterranean countries [26]. Human sera recognized multiple
bands of Lu. longipalpis saliva (figure 2A). One of the 2 human sera
also recognized two salivary proteins from Lu. intermedia (figure 2A).
We cannot exclude the possibility that this individual was weakly
exposed to Lu. intermedia bites, as this species is also present, albeit
rare, in Sa ˜o Luis [20] or to other non-abundant species in the area.
All tested sera recognized proteins between 28 and 50 kDa from
Lu. verrucarum saliva and a protein of approximately 40 kDa from
P. perniciosus saliva (figure 2A); both species do not overlap with Lu.
longipalpis in their geographical distribution.
Given that Lu. longipalpis and Lu. intermedia are sympatric in
several areas of Brazil [27] we decided to further investigate the
possibility of antibody cross-reactivity between these two species.
To address this, we tested six human sera from Canoa (an area in
Brazil endemic for CL where Lu. intermedia predominates) against
Figure 1. Lutzomyia longipalpis salivary proteins recognized by human, dog and fox sera from the visceral leishmaniasis endemic
areas of Sa ˜o Luis and Teresina. A, Silver staining of a Bis-Tris NuPAGE gel of salivary proteins from Lu. longipalpis. B, Western Blot of salivary
proteins of Lu. longipalpis separated on a Tris-Glycine gel using a representative reactive sera from either human (Sa ˜o Luis), dog or fox (Teresina).
doi:10.1371/journal.pntd.0000638.g001
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www.plosntds.org 3 March 2010 | Volume 4 | Issue 3 | e638Figure 2. Detection of salivary proteins from different species of sand flies by Western Blot. A, Two representative human sera from Sa ˜o
Luis, a VL- endemic area where Lutzomyia longipalpis predominates, were screened against salivary proteins from Lu. longipalpis (LL), Lu. intermedia
(LI), Lu. verrucarum (LV), and Phlebotomus perniciosus (PPe). B, Western blot analysis of salivary proteins from Lu. longipalpis using human sera from
Canoa, a cutaneous leishmaniasis endemic area where Lu. intermedia predominates (CL endemic area; left bottom panel), or from Sa ˜o Luis where Lu.
longipalpis predominates (VL endemic area). Sera from individuals from a non-endemic area were used as negative controls (CTL–). The profile of
salivary proteins from Lu. intermedia recognized by a representative human serum (out of six tested ) from the Canoa endemic area (CL endemic area;
right bottom panel).
doi:10.1371/journal.pntd.0000638.g002
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salivary proteins of Lu. longipalpis but recognized those of Lu.
intermedia (figure 2B). Together, these results suggest an overall low
level of cross-reactivity between Lu. longipalpis and Lu. intermedia
salivary proteins.
Because in an endemic area there is no control of the diversity
and intensity of exposure of hosts to sand fly bites—both of which
can influence antibody response [14]—we compared dogs from
Teresina, where Lu. longipalpis is prevalent, with dogs experi-
mentally exposed to Lu. longipalpis bites. Overall, the reactivity of
sera from experimentally exposed dogs was considerably lower
than that of dogs from Teresina. Both dogs from Teresina and
experimentally exposed dogs recognized proteins between 15 to
65 kDa (figure 3). Both groups recognized multiple proteins in
Lu. longipalpis saliva but also a few in the saliva of Lu. verrucarum
and P. perniciosus. This, together with results from human sera,
suggests that antibodies against these proteins may be cross
reactive for these two species. Additionally, while proteins from
28 to 50 kDa from Lu. intermedia were recognized by sera of dogs
from Teresina, only one protein was poorly recognized by sera
from experimentally exposed dogs. Sera from foxes were also
tested but showed no cross-reactivity with the other species (data
not shown).
Production of soluble recombinant salivary protein in a
heterologous mammalian expression system
Nine abundant transcripts corresponding to the predicted
molecular weight of the most antigenic salivary proteins recognized
by human, dog, and fox sera within the range of 15 to 65 kDa
(figure 1) were selected for expression (Table 1). Figure 4 shows a
flow diagram of the approach used to express and purify the nine
chosen recombinant salivary proteins. Notably, the same DNA
plasmid is used for recombinant protein expression and antibody
production. Nine different salivary proteins were expressed and a
high level of purification was achieved by HPLC. Purification of
recombinant salivary protein LJM17 resulted in a well separated
peak eluting at 35–40 min (figure 4B). Aliquots of eluted fractions
were recognized by sera of mice immunized with LJM17 DNA
plasmid (figure 4C). SDS-PAGE of positive fractions shows a single
band of approximately 50 kDa (figure 4D), the expected size
predicted by the LJM17 transcript. Similar results were obtained
with the other eight expressed proteins: LJM111, LJM11, LJL143,
LJL13, LJL23, LJM04, LJL138, and LJL11 (data not shown).
Characterization of Lu. longipalpis immunogenic proteins
To determine whether the nine expressed salivary recombinant
proteins were recognized by sera from humans, dogs, and foxes,
Figure 3. Total IgG response in dogs from endemic areas and dogs experimentally exposed to Lutzomyia longipalpis bites. Dog sera
from Teresina, an area endemic for visceral leishmaniasis where Lu. longipalpis predominates, (Dog-VL endemic area) and sera from dogs
experimentally exposed to Lu. longipalpis bites (Dog – Experimentally exposed) were screened against salivary proteins from Lu. longipalpis (LL), Lu.
intermedia (LI), Lu. verrucarum (LV), and Phlebotomus perniciosus (PPe) by Western Blot.
doi:10.1371/journal.pntd.0000638.g003
Markers of Exposure to Lutzomyia longipalpis
www.plosntds.org 5 March 2010 | Volume 4 | Issue 3 | e638we chose those that recognized a considerable number of proteins
(from total sand fly saliva) with some degree of variability for
further analysis by western blot. Of the nine recombinant proteins
tested, LJM17, a yellow-related protein of 45 kDa, was the only
protein recognized by sera from the 3 different hosts (figure 5; data
for foxes not shown). LJM11, a 43-kDa protein also of the yellow
family of proteins, was recognized by human and dog sera, while a
third yellow-related protein, LJM111 (43 kDa) was only recog-
nized by human sera (figure 5). LJL23, LJL13, and LJM04
proteins were recognized only by dog sera; LJL143 was recognized
by dog sera and weakly recognized by human sera (figure 5).
LJL11 and LJL138 were not recognized by any of the sera tested
(data not shown).
To confirm the specificity of LJM17 and LJM11 as potential
markers of Lu. longipalpis exposure, we tested human sera from Sa ˜o
Luis and Canoa where Lu. longipalpis and Lu. intermedia predom-
inate, respectively. Both LJM17 and LJM11 were recognized
specifically by human sera from Sa ˜o Luis but not from Canoa
(figure 6).
Discussion
Among parasitic diseases, leishmaniasis has one of the most
complex epidemiologies. There are numerous Leishmania species
and some cause a wide range of clinical manifestations and involve
a large number of proven and potential reservoir hosts. In most
cases, each form of leishmaniasis is transmitted by a sand fly
species that acts as a principal vector; a few Leishmania species
have multiple vector species [28]. In addition, endemic areas of
leishmaniasis support several sand fly species other than the vector
species responsible for Leishmania transmission. Finding tools to
measure exposure of humans and reservoir hosts to specific vectors
would provide valuable information regarding their contribution
to parasite transmission and would be useful for assessing the risk
of contracting disease.
Several studies have demonstrated that anti-saliva antibodies
can be used to assess exposure of humans and other Leishmania
hosts to sand fly bites and suggested that sand fly salivary proteins
represent attractive targets for development of specific markers of
vector exposure [4,14,16]. To date, none of the salivary proteins of
sand flies have been characterized for their immunogenicity and
specificity in mammalian hosts, an important prerequisite for their
reliability as markers of exposure.
In the present work, we developed a robust method for
producing and purifying recombinant salivary proteins. This
approach proved highly successful in obtaining pure recombi-
nant proteins that retain recognition epitopes. The purity of the
produced recombinant salivary pr o t e i n si sd e m o n s t r a t e db yt h e
presence of a single protein band following SDS-PAGE and
silver staining; this level of purity was obtained for all
recombinant salivary proteins tested. Soluble and pure recom-
binant proteins are likely to be properly folded and to better
resemble native proteins. This should improve the sensitivity of
the detection, enhancing recognition of such proteins by test
sera and increasing the specificity of a test by decreasing the
chances of false negatives often caused by impurities in the
preparation. It is worth noting that the tested salivary
recombinant proteins demonstrated specific responses, as two
(LJL11 and LJL138) of the nine proteins were not recognized by
any of the tested sera.
The seven immunogenic recombinant salivary proteins were
differentially recognized by human, dog, and fox sera, the three
host species investigated. Some proteins displayed host-specific
recognition, reinforcing the importance of testing potential
salivary markers for exposure against a variety of hosts to
determine their range of applicability. Recombinant proteins
LJM17 and LJM11 were strongly recognized by human sera from
Sa ˜o Luis, a VL endemic area where Lu. longipalpis predominates,
representing 66.4% of captured sand flies [29]. Notably, human
sera obtained from Canoa, a CL area where Lu. intermedia
represents 94% of the sand fly population [22], did not recognize
LJM17 or LJM11. Lu. longipalpis and Lu. intermedia are sympatric
species in many endemic areas of Brazil, often representing the
two most abundant sand fly species [27]. As such, LJM17 and
LJM11 can be considered as potential specific markers of
exposure to Lu. longipalpis in areas where other man-biting sand
fly species are present in negligible numbers [20,24,27]. LJM17
and LJM11 should be tested for specificity against other man-
biting sand fly species that are relatively abundant in endemic
areas—such as Lutzomyia whitmani [29]—to expand their utility as
specific markers of exposure to Lu. longipalpis. Indeed, the faint
bands recognized in Lu. intermedia saliva against one reactive
human serum from Sa ˜o Luis (figure 2) may have been due to
cross reactivity between salivary proteins of this species and those
of Lu. whitmani, reported to constitute as much as 24% of the sand
fly population in this area [29]. The absolute specificity of LJM17
and LJM11 for Lu. longipalpis exposure therefore requires further
confirmation through studies that target more sand fly species.
Serum samples from Sa ˜o Luis also recognized salivary proteins
from P. perniciosus, a vector of VL in the Old World [30]. This is
Table 1. Transcripts selected from a Lutzomyia longipalpis salivary gland cDNA library based on predicted molecular weight of
secreted proteins.
Transcript Predicted molecular weight Annotation NCBI accession number
LJM17 45.2 Yellow related protein AF132518
LJM11 43.2 Yellow related protein AY445935
LJM111 43.0 Yellow related protein DQ192488
LJL23 35.1 Apyrase AF131933
LJL13 26.5 D7 related protein AF420274
LJM04 13.8 SL1 protein AAD32197.1
LJL138 43.7 Endonuclease AY455916
LJL11 60.5 5
/nucleotidase AF132510
LJL143 32.4 Unknown AY445936
doi:10.1371/journal.pntd.0000638.t001
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www.plosntds.org 6 March 2010 | Volume 4 | Issue 3 | e638Figure 4. Production of recombinant sand fly salivary proteins. A, Flowchart describing the expression, purification and detection of
recombinant sand fly salivary proteins from Lutzomyia longipalpis. B, Chromatogram of the purification of the LJM17 recombinant protein by HPLC-
metal affinity chromatography. C, Detection of positive fractions for the LJM17 recombinant protein using sera from mice immunized with LJM17
plasmid. D, Silver-stained SDS-PAGE of LJM17 recombinant protein before (1) and after (2) HPLC purification.
doi:10.1371/journal.pntd.0000638.g004
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P. papatasi and P. sergenti—two established Old World CL
vectors—are abundant, did not react with salivary proteins of
Lu. longipalpis [16].
Both LJM17 and LJM11 were recognized by dog sera from
Teresina, endemic for canine VL [19]. A recent survey of the sand
fly population from this area showed that Lu. longipalpis represented
99.7% of the collection [20]. Different from work done previously,
here we detected six different salivary proteins as potential specific
markers for exposure to Lu. longipalpis by using recombinant
proteins for dogs (figure 5). The dog-biting status of other Lutzomyia
species needs to be established before the specificity of these
proteins as markers of exposure to Lu. longipalpis can be validated.
However, this does not detract from their usefulness as potential
markers for sand fly exposure for the evaluation of intervention
studies in dogs.
Although we did not test potential cross-reactivity of LJM17 and
LJM11 with salivary proteins from other common vectors such as
mosquitoes, kissing bugs, and black flies, extensive comparative
transcriptomic analysis confirm that these two proteins are unique
and distinct from those in the saliva of other arthropod vectors
[31–35].
In conclusion, we have identified two salivary proteins from Lu.
longipalpis, LJM17 and LJM11, that were specifically recognized by
sera from humans living in an endemic area of VL. Once tested on
a wider scale, these proteins could become an important tool for
accurate surveillance of this important vector of VL in Latin
America.
Figure 5. Detection of Lutzomyia longipalpis recombinant salivary proteins by human and dog sera from visceral leishmaniasis
endemic areas. Human and dog sera from Sa ˜o Luis and Teresina respectively, were used to screen recombinant salivary proteins LJM17,
LJM11, LJM111, LJL13, LJL23, LJM04, and LJL143 by Western Blot (+). Human and dog sera from a non-endemic area were used as negative
controls (–).
doi:10.1371/journal.pntd.0000638.g005
Markers of Exposure to Lutzomyia longipalpis
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